• Nexvet Biopharma (Nasdaq: NVET) in its US$40 million initial public offering
  • Adaptive Biotechnologies, Inc. in its acquisition of Sequenta, Inc.
  • The underwriters in the US$82 million initial public offering for Trupanion (NYSE: TRUP)
  • Avalara, Inc. in its acquisition of the line of Zytax energy-related tax automation solutions
  • A biotechnology company in its US$60 million common stock financing
  • Avalara, Inc. in its US$30 million Series D preferred stock financing